WallStSmart

Lifestance Health Group Inc (LFST)vsNovartis AG ADR (NVS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Novartis AG ADR generates 3477% more annual revenue ($56.69B vs $1.58B). NVS leads profitability with a 22.5% profit margin vs 3.2%. NVS trades at a lower P/E of 20.7x. NVS earns a higher WallStSmart Score of 51/100 (C-).

LFST

Hold

48

out of 100

Grade: D+

Growth: 8.7Profit: 4.5Value: 5.7Quality: 7.0
Piotroski: 6/9Altman Z: 1.59

NVS

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 9.0Value: 3.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LFSTUndervalued (+36.0%)

Margin of Safety

+36.0%

Fair Value

$10.83

Current Price

$12.97

$2.14 discount

UndervaluedFair: $10.83Overvalued
NVSSignificantly Overvalued (-47.0%)

Margin of Safety

-47.0%

Fair Value

$93.29

Current Price

$137.16

$43.87 premium

UndervaluedFair: $93.29Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LFST3 strengths · Avg: 9.0/10
EPS GrowthGrowth
1927.0%10/10

Earnings expanding 1927.0% YoY

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
26.1%8/10

Revenue surging 26.1% year-over-year

NVS5 strengths · Avg: 9.4/10
Market CapQuality
$260.70B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
30.7%10/10

Every $100 of equity generates 31 in profit

Operating MarginProfitability
34.6%10/10

Strong operational efficiency at 34.6%

Profit MarginProfitability
22.5%9/10

Keeps 23 of every $100 in revenue as profit

Free Cash FlowQuality
$5.57B8/10

Generating 5.6B in free cash flow

Areas to Watch

LFST4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Return on EquityProfitability
1.6%3/10

ROE of 1.6% — below average capital efficiency

Profit MarginProfitability
3.2%3/10

3.2% margin — thin

P/E RatioValuation
97.1x2/10

Premium valuation, high expectations priced in

NVS4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Debt/EquityHealth
1.183/10

Elevated debt levels

PEG RatioValuation
3.222/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : LFST

The strongest argument for LFST centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 26.1% demonstrates continued momentum.

Bull Case : NVS

The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 22.5% and operating margin at 34.6%.

Bear Case : LFST

The primary concerns for LFST are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 97.1x leaves little room for execution misses. Thin 3.2% margins leave little buffer for downturns.

Bear Case : NVS

The primary concerns for NVS are Revenue Growth, Altman Z-Score, Debt/Equity.

Key Dynamics to Monitor

LFST profiles as a growth stock while NVS is a value play — different risk/reward profiles.

LFST carries more volatility with a beta of 1.22 — expect wider price swings.

LFST is growing revenue faster at 26.1% — sustainability is the question.

NVS generates stronger free cash flow (5.6B), providing more financial flexibility.

Bottom Line

NVS scores higher overall (51/100 vs 48/100), backed by strong 22.5% margins. LFST offers better value entry with a 36.0% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lifestance Health Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

LifeStance Health Group, Inc., provides outpatient mental health services to children, adolescents, adults and geriatrics. The company is headquartered in Scottsdale, Arizona.

Novartis AG ADR

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.

Visit Website →

Want to dig deeper into these stocks?